The IPO Buzz: Obesity-Focused Kailera Therapeutics Sets $500 Million IPO

Kailera Therapeutics (KLRA Proposed), which is developing a weekly GLP-1 shot and a daily pill to help people lose weight, launched its $500 million IPO with an S-1/A filing early today – Monday, April 13, 2026. Kailera Therapeutics disclosed the terms – 33.33 million shares at a price range of $14.00 to $16.00 per share […]

April 13, 2026 Read More

The IPO Buzz: HMH Holding (HMH) Prices IPO at $20 – Below Mid-Point

Houston-based HMH Holding (HMH) priced its IPO at $20.00 – just below the mid-point of its $19.00-to-$22.00 range –  and sold 10.52 million shares – the number in the prospectus – to raise $210.4 million on Tuesday night, March 31, 2026. HMH Holding’s stock slipped in its NASDAQ debut on Wednesday, April 1, 2026 – opening at […]

March 31, 2026 Read More